These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1723835)

  • 41. Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: the Oxford Regional Prospective Study.
    Amin R; Williams RM; Frystyk J; Umpleby M; Matthews D; Orskov H; Dalton RN; Dunger DB
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):137-44. PubMed ID: 15670188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth hormone-insulin-like growth factor-I axis in adult insulin-dependent diabetic patients: evidence for central hypersensitivity to growth hormone-releasing hormone and peripheral resistance to growth hormone.
    Fainstein Day P; Fagin JA; Vaglio RM; Litwak LE; Picasso MF; Gutman RA
    Horm Metab Res; 1998 Dec; 30(12):737-42. PubMed ID: 9930632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects.
    Rasmussen MH; Hvidberg A; Juul A; Main KM; Gotfredsen A; Skakkebaek NE; Hilsted J; Skakkebae NE
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1407-15. PubMed ID: 7536210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.
    Insler V; Barash A; Shoham Z; Koistinen R; Seppala M; Hen M; Lunenfeld B; Zadik Z
    Isr J Med Sci; 1994 Jan; 30(1):42-7. PubMed ID: 7511134
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is IGF binding protein-3 assessment helpful for the diagnosis of GH deficiency?
    Cianfarani S; Boemi S; Spagnoli A; Cappa M; Argirò G; Vaccaro F; Manca Bitti ML; Boscherini B
    Clin Endocrinol (Oxf); 1995 Jul; 43(1):43-7. PubMed ID: 7543832
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential impact of simple childhood obesity on the components of the growth hormone-insulin-like growth factor (IGF)-IGF binding proteins axis.
    Ballerini MG; Ropelato MG; Domené HM; Pennisi P; Heinrich JJ; Jasper HG
    J Pediatr Endocrinol Metab; 2004 May; 17(5):749-57. PubMed ID: 15237710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.
    Van den Berghe G; Baxter RC; Weekers F; Wouters P; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2000 Jan; 85(1):183-92. PubMed ID: 10634385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low plasma growth hormone binding protein in IDDM.
    Mercado M; Molitch ME; Baumann G
    Diabetes; 1992 May; 41(5):605-9. PubMed ID: 1568530
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin-like growth factor (IGF)-I and -II and IGF-binding proteins-1, -2, and -3 in children and adolescents with diabetes mellitus: correlation with metabolic control and height attainment.
    Strasser-Vogel B; Blum WF; Past R; Kessler U; Hoeflich A; Meiler B; Kiess W
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1207-13. PubMed ID: 7536202
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
    Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nonparallel changes of growth hormone (GH) and insulin-like growth factor-I, insulin-like growth factor binding protein-3, and GH-binding protein, after craniospinal irradiation and chemotherapy.
    Nivot S; Benelli C; Clot JP; Saucet C; Adan L; Souberbielle JC; Zucker JM; Rappaport R; Brauner R
    J Clin Endocrinol Metab; 1994 Mar; 78(3):597-601. PubMed ID: 7510304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Function of the growth hormone-insulin-like growth factor I axis in the profoundly growth-retarded diabetic child: evidence for defective target organ responsiveness in the Mauriac syndrome.
    Mauras N; Merimee T; Rogol AD
    Metabolism; 1991 Oct; 40(10):1106-11. PubMed ID: 1719338
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of insulin-like growth factor binding protein-1 (IGFBP-1) in insulin-dependent diabetes mellitus. Effects of hyperglycaemia and insulin.
    Fowelin J; Attvall S; von Schenck H; Smith U; Lager I; Hall K
    Acta Diabetol; 1994 Dec; 31(4):183-6. PubMed ID: 7534144
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth.
    McIntyre HD; Serek R; Crane DI; Veveris-Lowe T; Parry A; Johnson S; Leung KC; Ho KK; Bougoussa M; Hennen G; Igout A; Chan FY; Cowley D; Cotterill A; Barnard R
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1143-50. PubMed ID: 10720053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recombinant human insulin-like growth factor-I abolishes changes in insulin requirements consequent upon growth hormone pulsatility in young adults with type I diabetes mellitus.
    Crowne EC; Samra JS; Cheetham T; Watts A; Holly JM; Dunger DB
    Metabolism; 1998 Jan; 47(1):31-8. PubMed ID: 9440474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback.
    Ismail IS; Scanlon MF; Peters JR
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):149-57. PubMed ID: 8094648
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of recombinant human IGF-I administration on concentrations of acid labile subunit, IGF binding protein-3, IGF-I, IGF-II and proteolysis of IGF binding protein-3 in adolescents with insulin-dependent diabetes mellitus.
    Cheetham TD; Holly JM; Baxter RC; Meadows K; Jones J; Taylor AM; Dunger DB
    J Endocrinol; 1998 Apr; 157(1):81-7. PubMed ID: 9614361
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The study of spontaneous GH secretion after 36-h fasting distinguishes between GH-deficient and normal adults.
    Aimaretti G; Colao A; Corneli G; Pivonello R; MacCario M; Morrison K; Pflaum CD; Strasburger CJ; Lombardi G; Ghigo E
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):771-7. PubMed ID: 10619983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of 24-hour growth hormone secretion in acromegaly: implications for diagnosis and therapy.
    Ho KY; Weissberger AJ
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):75-83. PubMed ID: 8050134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction.
    Argente J; Caballo N; Barrios V; Pozo J; Muñoz MT; Chowen JA; Hernández M
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2076-83. PubMed ID: 9215275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.